Argent Biopharma (ASX:RGT) Revenue : A$1.67 Mil (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Argent Biopharma Revenue?

Argent Biopharma's revenue for the six months ended in Dec. 2023 was A$0.94 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.67 Mil. Argent Biopharma's Revenue per Share for the six months ended in Dec. 2023 was A$0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.26.

Warning Sign:

Argent Biopharma Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Argent Biopharma was -85.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -8.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 37.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Argent Biopharma's highest 3-Year average Revenue per Share Growth Rate was 129.80% per year. The lowest was -8.60% per year. And the median was 65.45% per year.

Argent Biopharma Revenue Historical Data

The historical data trend for Argent Biopharma's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argent Biopharma Revenue Chart

Argent Biopharma Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Revenue

Get a 7-Day Free Trial

0.66

2.08

2.96

4.73

3.39

Argent Biopharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Revenue	Get a 7-Day Free Trial															2.57	2.17	2.66	0.73	0.94

Competitive Comparison of Argent Biopharma's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argent Biopharma's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's Revenue distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's Revenue falls into.

Argent Biopharma Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.67 Mil.

Argent Biopharma (ASX:RGT) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Argent Biopharma Revenue Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Argent Biopharma (ASX:RGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (ASX:RGT) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

MGCLF:USA MXC:UK H5O:Germany

Address

295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008

Website

https://mgcpharma.co.uk

MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.